| Therapy | Medication |
| CHEMOTHERAPY | DOCETAXEL |
| PEMETREXED (ALIMTA) | |
| PACLITAXEL | |
| NAVELBIN | |
| CYCLOPHOSPHAMIDE | |
| CARBOPLATIN | |
| ETOPOSID | |
| MELPHALAN (ALKERAN) | |
| GEMCITABINE (GEMZAR) | |
| DOXORUBICIN | |
| COMBINATION CHEMOTHERAPY | EC (EPIRUBICIN, CYCLOPHOSPHAMIDE) |
| PACLITAXEL + NAVELBINE | |
| DOXORUBICIN + CYCLOPHOSPHAMIDE | |
| ENDOCRINE THERAPY | GOSERELIN (ZOLADEX) |
| ABIRATERON | |
| LETROZOLE | |
| RIBOCICLIB | |
| FULVESTRANT | |
| LEUPROLIDE ACETATE (ELIGARD) | |
| TAMOXIFEN | |
| BICALUTAMIDE | |
| MOLECULAR-TARGETED THERAPY | PALBOCICLIB |
| BORTEZOMIB | |
| ABEMACICLIB | |
| PERTUZUMAB | |
| TRASTUZUMAB(HERCEPTIN) | |
| OSIMERTINIB | |
| SUNITINIB (SUTENT) | |
| CABOZANTINIB | |
| COMBINATION CHEMOTHERAPY/HORMONOTHERAPY AND TARGETED MOLECULAR THERAPY | ATEZOLIZUMAB + ETOPOSID + CRB |
| CYBORD (CYCLOPHOSPHAMIDE + BORTEZOMIB + DEXAMETHASONE) | |
| TAMOXIFEN + ABEMACICLIB + FULVESTRANT | |
| PALBOCICLIB + FULVESTRANT | |
| PALBOCICLIB + LETROZOLE | |
| AHT | ATEZOLIZUMAB |
| PEMBROLIZUMAB |